Drugs Industry, Merck & Co. | featured news

Merck's Heart Failure Failure

One of the drug industry's most renowned names is having a lot of trouble landing new drugs.

 

Merck to buy Schering-Plough in $41.1 billion deal

Merck to buy Schering-Plough in $41.1 billion deal

Drugmakers Merck & Co. and Schering-Plough Corp. are planning to merge under the name Merck in a stock-and-cash deal worth about $41.1 billion.

 

Subscribe to this RSS topic: Syndicate content